Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05783297Not ApplicableCompleted

Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

Role: collaborator

NCT07346508Not ApplicableNot Yet Recruiting

Project SPEED - Streamlined Protocol for Early Engagement and Delivery of HIV Prevention With Long-acting Injectable Cabotegravir: A Nurse-driven Protocol

Role: lead

NCT05208541Recruiting

Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables

Role: collaborator

All 3 trials loaded